Piquette RK |
Torsade de pointes induced by cisapride/clarithromycin interaction. |
1999 |
Ann Pharmacother |
pmid:9972380
|
Yonemochi E et al. |
Physicochemical properties of amorphous clarithromycin obtained by grinding and spray drying. |
1999 |
Eur J Pharm Sci |
pmid:9971917
|
Desta Z et al. |
Effect of clarithromycin on the pharmacokinetics and pharmacodynamics of pimozide in healthy poor and extensive metabolizers of cytochrome P450 2D6 (CYP2D6). |
1999 |
Clin. Pharmacol. Ther. |
pmid:9951426
|
Principi N and Esposito S |
Comparative tolerability of erythromycin and newer macrolide antibacterials in paediatric patients. |
1999 |
Drug Saf |
pmid:9935275
|
Lindeboom JA et al. |
Clarithromycin as a single-modality treatment in mycobacterial avium-intracellular infections. |
1999 |
Oral Surg Oral Med Oral Pathol Oral Radiol Endod |
pmid:9927080
|
GarcÃa-Arata MI et al. |
Mutations in 23S rRNA in Helicobacter pylori conferring resistance to erythromycin do not always confer resistance to clarithromycin. |
1999 |
Antimicrob. Agents Chemother. |
pmid:9925537
|
Stefansson P et al. |
Cefuroxime axetil versus clarithromycin in the treatment of acute maxillary sinusitis. |
1998 |
Rhinology |
pmid:9923060
|
Matsushima T and Miyashita N |
[Basic and clinical study of Chlamydia pneumoniae infections]. |
1998 |
Nippon Naika Gakkai Zasshi |
pmid:9922675
|
Kuipers EJ and Klinkenberg-Knol EC |
Helicobacter pylori, acid, and omeprazole revisited: bacterial eradication and rebound hypersecretion. |
1999 |
Gastroenterology |
pmid:9922329
|
Lind T et al. |
The MACH2 study: role of omeprazole in eradication of Helicobacter pylori with 1-week triple therapies. |
1999 |
Gastroenterology |
pmid:9922303
|
Garrido A et al. |
[Eradication of Helicobacter pylori by triple therapy in ulcerous patients: the role of endoscopy and antibiotic sensitivity]. |
1998 |
Enferm. Infecc. Microbiol. Clin. |
pmid:9918994
|
Miglioli PA et al. |
Antibacterial activity of human pleural fluid: alone and in combination with antibiotics. |
1998 |
Int. J. Antimicrob. Agents |
pmid:9916908
|
Fera MT et al. |
Bactericidal activity of lansoprazole and three macrolides against Helicobacter pylori strains tested by the time-kill kinetic method. |
1998 |
Int. J. Antimicrob. Agents |
pmid:9916902
|
Lacy MK et al. |
Comparison of bactericidal activity after multidose administration of clarithromycin, azithromycin, and ceruroxime axetil against Streptococcus pneumoniae. |
1998 |
Int. J. Antimicrob. Agents |
pmid:9916901
|
Abe M et al. |
A case of diffuse panbronchiolitis effectively treated with low-dose macrolide antibiotics and leukotriene D4/E4 receptor antagonist. |
1998 |
Respir Med |
pmid:9893782
|
Savarino V et al. |
Optimal duration of therapy combining ranitidine bismuth citrate with clarithromycin and metronidazole in the eradication of Helicobacter pylori infection. |
1999 |
Aliment. Pharmacol. Ther. |
pmid:9892878
|
Einarson A et al. |
A prospective controlled multicentre study of clarithromycin in pregnancy. |
1998 |
Am J Perinatol |
pmid:9890248
|
Lygren I et al. |
[Treatment of Helicobacter pylori infection]. |
1998 |
Tidsskr. Nor. Laegeforen. |
pmid:9889634
|
Williams SL et al. |
Development of a firefly luciferase-based assay for determining antimicrobial susceptibility of Mycobacterium avium subsp. paratuberculosis. |
1999 |
J. Clin. Microbiol. |
pmid:9889208
|
Baena DÃez JM et al. |
[Treatment with omeprazole, clarithromycin and amoxicillin for one week. Their efficacy and tolerance in eradicating Helicobacter pylori in primary care]. |
1998 |
Aten Primaria |
pmid:9887574
|
Gisbert JP et al. |
[Previous treatment with omeprazole and H. pylori: does it diminish the eradication efficacy of the "new" triple therapies of one week's duration?]. |
1998 |
Med Clin (Barc) |
pmid:9887438
|
Tohnai A et al. |
Clarithromycin suppresses proliferation of rat nasal epithelium exposed to endotoxin. |
1998 Nov-Dec |
Am J Rhinol |
pmid:9883303
|
MartÃn Mir ML et al. |
[Effectiveness of the eradication of Helicobacter pylori by treatment with omeprazol, amoxicillin, and clarithromycin according to dosage and administration schedule]. |
1998 |
Gastroenterol Hepatol |
pmid:9882932
|
Komori T et al. |
Effects of repeated clarithromycin administration on the pharmacokinetic properties of pindolol in rats. |
1998 |
Biol. Pharm. Bull. |
pmid:9881659
|
Sakamoto M et al. |
[Effect of clarithromycin treatment of natural killer cell activity in patients with advanced non-small cell lung cancer]. |
1998 |
Gan To Kagaku Ryoho |
pmid:9881083
|
Vorbach H et al. |
Endothelial cell compatibility of clarithromycin for intravenous use. |
1998 |
Clin. Biochem. |
pmid:9876898
|
Matteelli A et al. |
Long term treatment with clarithromycin for cryptosporidiosis and emergence of drug resistant disseminated infection due to Mycobacterium avium: case report. |
1998 |
J Chemother |
pmid:9876056
|
Komori T et al. |
Effect of clarithromycin on alpha1-acid glycoprotein levels in normal and diabetic rats. |
1998 |
Res. Commun. Mol. Pathol. Pharmacol. |
pmid:9874281
|
Sakurai N et al. |
Synthesis and structure-activity relationships of 7-(2-aminoalkyl)morpholinoquinolones as anti-Helicobacter pylori agents. |
1998 |
Bioorg. Med. Chem. Lett. |
pmid:9873510
|
Yoshida Y et al. |
Discovery of a novel benzyloxyisoquinoline derivative with potent anti-Helicobacter pylori activity. |
1998 |
Bioorg. Med. Chem. Lett. |
pmid:9873455
|
Sakaki N et al. |
Preliminary study on a novel quadruple eradication therapy with a mucoprotective drug, sofalcone, for Helicobacter pylori infection. |
1998 |
J. Clin. Gastroenterol. |
pmid:9872520
|
Suzuki J et al. |
Relationship between the eradication of Helicobacter pylori and the healing pattern of peptic ulcer. |
1998 |
J. Clin. Gastroenterol. |
pmid:9872515
|
Lee CL et al. |
One-week low-dose triple therapy is effective in treating Helicobacter pylori-infected patients with bleeding peptic ulcers. |
1998 |
J. Formos. Med. Assoc. |
pmid:9872028
|
Waddell ST et al. |
Synthesis and antibacterial activity of O-methyl derivatives of azalide antibiotics: II. 6-OME derivatives via clarithromycin. |
1998 |
Bioorg. Med. Chem. Lett. |
pmid:9871759
|
van Westrhenen R et al. |
Pneumonia and glomerulonephritis caused by Mycoplasma pneumoniae. |
1998 |
Nephrol. Dial. Transplant. |
pmid:9870493
|
Sassa K et al. |
Therapeutic effect of clarithromycin on a transplanted tumor in rats. |
1999 |
Antimicrob. Agents Chemother. |
pmid:9869567
|
Shafran SD et al. |
Does in vitro susceptibility to rifabutin and ethambutol predict the response to treatment of Mycobacterium avium complex bacteremia with rifabutin, ethambutol, and clarithromycin? Canadian HIV Trials Network Protocol 010 Study Group. |
1998 |
Clin. Infect. Dis. |
pmid:9868650
|
Wallace RJ and Brown BA |
Catheter sepsis due to Mycobacterium chelonae. |
1998 |
J. Clin. Microbiol. |
pmid:9867491
|
Al-Sibai MB et al. |
Ocular penetration of oral clarithromycin in humans. |
1998 |
J Ocul Pharmacol Ther |
pmid:9867340
|
Maeda S et al. |
Helicobacter pylori specific nested PCR assay for the detection of 23S rRNA mutation associated with clarithromycin resistance. |
1998 |
Gut |
pmid:9863474
|
Blum AL et al. |
Lack of effect of treating Helicobacter pylori infection in patients with nonulcer dyspepsia. Omeprazole plus Clarithromycin and Amoxicillin Effect One Year after Treatment (OCAY) Study Group. |
1998 |
N. Engl. J. Med. |
pmid:9862942
|
Adelglass J et al. |
A multicenter, investigator-blinded, randomized comparison of oral levofloxacin and oral clarithromycin in the treatment of acute bacterial sinusitis. |
1998 Nov-Dec |
Pharmacotherapy |
pmid:9855324
|
Shimoyama T et al. |
Healing of cimetidine-resistant Ménétrier's disease by eradication of Helicobacter pylori infection. |
1998 |
J. Clin. Gastroenterol. |
pmid:9855268
|
Cadwgan AM et al. |
Neisseria meningitidis W135 pneumonia with sepicaemia in a nonogenarian. |
1998 |
Scott Med J |
pmid:9854302
|
Coudron PE and Stratton CW |
In-vitro evaluation of nitrofurantoin as an alternative agent for metronidazole in combination antimicrobial therapy against Helicobacter pylori. |
1998 |
J. Antimicrob. Chemother. |
pmid:9848452
|
Gudjonsson H et al. |
High Helicobacter pylori eradication rate with a 1-week regimen containing ranitidine bismuth citrate. |
1998 |
Aliment. Pharmacol. Ther. |
pmid:9845401
|
Gisbert JP et al. |
[Role of pantoprazole in the eradicating treatment of Helicobacter pylori]. |
1998 |
Rev Clin Esp |
pmid:9844458
|
Gisbert JP et al. |
[Omeprazole plus 2 antibiotics for the eradication of H. pylori, are 5 days of treatment sufficient?]. |
1998 |
Rev Clin Esp |
pmid:9844453
|
Kato S et al. |
Safety and efficacy of one-week triple therapy for eradicating Helicobacter pylori in children. |
1998 |
Helicobacter |
pmid:9844069
|
Ohkusa T et al. |
Disappearance of hyperplastic polyps in the stomach after eradication of Helicobacter pylori. A randomized, clinical trial. |
1998 |
Ann. Intern. Med. |
pmid:9841603
|